INSMED Inc (28)

Browse by Contract Category

Contracts

Sales Agreement, dated as of February 25 2021, between SVB Leerink LLC and Insmed Incorporated (Filed With SEC on February 25, 2021)
Form of Award Agreement for Restricted Stock Units issued to directors pursuant to the Insmed Incorporated 2019 Incentive Plan (Filed With SEC on February 25, 2021)
Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 25, 2021)
License Agreement, dated April 25, 2008, between Transave, Inc. and PARI Pharma GmbH, and Amendments No. 1-4 thereto (Filed With SEC on October 29, 2020)
Underwriting Agreement, dated May 4, 2020, by and between Insmed Incorporated and SVB Leerink LLC, as representative of the underwriters named in Schedule I thereto (Filed With SEC on May 7, 2020)
Second Amendment to Lease, dated October 17, 2018, between CIP II/AR Bridgewater Holdings LLC and Insmed Incorporated (Filed With SEC on May 7, 2019)
Form of Award Agreement for Non-Qualified Stock Options pursuant to the Insmed Incorporated 2019 Incentive Plan (Filed With SEC on February 25, 2021)
Form of Award Agreement for Restricted Stock Units pursuant to the Insmed Incorporated 2019 Incentive Plan (Filed With SEC on February 25, 2021)
Omnibus Amendment to Insmed Incorporated Incentive Plans, dated December 10, 2020 (Filed With SEC on February 25, 2021)
Amending Agreement, dated March 13, 2014, between Insmed Incorporated and Therapure Biopharma Inc (Filed With SEC on October 29, 2020)
Contract Manufacturing Agreement, dated February 7, 2014, between Insmed Incorporated and Therapure Biopharma Inc (Filed With SEC on October 29, 2020)
Second Amendment to Employment Agreement, effective as of July 31, 2019, between Insmed Incorporated and S. Nicole Schaeffer (Filed With SEC on April 30, 2020)
Employment Agreement, effective as of January 28, 2020, between Insmed Incorporated and Sara Bonstein (Filed With SEC on February 25, 2020)
Employment Agreement, effective as of March 17, 2014, between Insmed Incorporated and John Goll (Filed With SEC on February 25, 2020)
Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 25, 2020)
Second Amendment to Employment Agreement, effective as of July 31, 2019, between Insmed Incorporated and Christine Pellizzari (Filed With SEC on August 1, 2019)
Amendment to Employment Agreement, effective as of July 31, 2019, between Insmed Incorporated and Roger Adsett (Filed With SEC on August 1, 2019)
Amendment to Employment Agreement, effective as of July 31, 2019, between Insmed Incorporated and William H. Lewis (Filed With SEC on August 1, 2019)
Form of Award Agreement for Restricted Stock Units issued to directors pursuant to the Insmed Incorporated 2019 Incentive Plan (Filed With SEC on August 1, 2019)
Form of Non-Qualified Stock Option Agreement under the Insmed Incorporated 2019 Incentive Plan (Filed With SEC on August 1, 2019)
Form of Restricted Unit Award Agreement under the Insmed Incorporated 2019 Incentive Plan (Filed With SEC on August 1, 2019)
Insmed Incorporated 2019 Incentive Plan (Filed With SEC on August 1, 2019)
Underwriting Agreement, dated May 21, 2019, by and among Insmed Incorporated, William H. Lewis and Morgan Stanley & Co. LLC, SVB Leerink LLC and Goldman Sachs & Co. LLC, as... (Filed With SEC on May 24, 2019)
Separation Agreement and General Release between Insmed Incorporated and Paolo Tombesi, dated as of May 3, 2019 (Filed With SEC on May 7, 2019)
First Amendment to Lease, dated October 1, 2016, between CIP II/AR Bridgewater Holdings LLC and Insmed Incorporated (Filed With SEC on May 7, 2019)
Form of Award Agreement for Restricted Stock Units issued to directors pursuant to the Insmed Incorporated 2017 Incentive Plan (Filed With SEC on May 7, 2019)
Extension of Commercial Fill/Finish Services Agreement between Insmed Incorporated and Ajinomoto Althea, Inc., dated as of December 18, 2018 (Filed With SEC on February 22, 2019)
Amendment No. 8 to License Agreement between Insmed Incorporated and PARI Pharma GmbH, effective as of December 19, 2018 (Filed With SEC on February 22, 2019)